Urinary symptom flare following I-125 prostate brachytherapy. (Q53300115)

13 May 2018

title

Urinary symptom flare following I-125 prostate brachytherapy. (English)

1 reference

13 May 2018

1 reference

Jamie A Cesaretti

1

1 reference

13 May 2018

Nelson N Stone

series ordinal

2

1 reference

13 May 2018

Richard G Stock

series ordinal

3

1 reference

13 May 2018

language of work or name

English

0 references

publication date

1 July 2003

1 reference

13 May 2018

International Journal of Radiation Oncology Biology Physics

published in

1 reference

13 May 2018

volume

56

1 reference

13 May 2018

issue

4

1 reference

13 May 2018

page(s)

1085-1092

1 reference

13 May 2018

Treatments for prostate cancer in older men: 1984-1997.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900210-4

7 January 2021

The National Cancer Data Base report on prostate carcinoma after the peak in incidence rates in the U.S. The American College of Surgeons Commission on Cancer and the American Cancer Society

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900210-4

7 January 2021

10-year biochemical (prostate-specific antigen) control of prostate cancer with (125)I brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900210-4

7 January 2021

Transperineal 125iodine implantation for treatment of clinically localized prostate cancer: 5-year tumor control and morbidity

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900210-4

7 January 2021

A prospective quality-of-life study in men with clinically localized prostate carcinoma treated with radical prostatectomy, external beam radiotherapy, or interstitial brachytherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900210-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900210-4

7 January 2021

Tumor control and morbidity following transperineal iodine 125 implantation for stage T1/T2 prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900210-4

7 January 2021

Acute urinary morbidity following I-125 interstitial implantation of the prostate gland

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900210-4

7 January 2021

Urinary morbidity following ultrasound-guided transperineal prostate seed implantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900210-4

7 January 2021

Temporal resolution of urinary morbidity following prostate brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900210-4

7 January 2021

The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900210-4

7 January 2021

A modified technique allowing interactive ultrasound-guided three-dimensional transperineal prostate implantation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900210-4

7 January 2021

Postimplant dosimetry for (125)I prostate implants: definitions and factors affecting outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900210-4

7 January 2021

Importance of post-implant dosimetry in permanent prostate brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900210-4

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900210-4

7 January 2021

Prostate specific antigen bounce after radioactive seed implantation followed by external beam radiation for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900210-4

7 January 2021

Quality of life after permanent prostate implant.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900210-4

7 January 2021

Importance of individual response in symptom score evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900210-4

7 January 2021

Symptoms and quality of life versus age, prostate volume, and urodynamic parameters in 565 strictly selected men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900210-4

7 January 2021

Correlation between uroflowmetry, prostate volume, postvoid residue, and lower urinary tract symptoms as measured by the International Prostate Symptom Score.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900210-4

7 January 2021

Relationship of Symptoms of Prostatism to Commonly Used Physiological and Anatomical Measures of the Severity of Benign Prostatic Hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900210-4

7 January 2021

Prostate volume predicts outcome of treatment of benign prostatic hyperplasia with finasteride: Meta-analysis of randomized clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900210-4

7 January 2021

Permanent seed implantation for localized adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900210-4

7 January 2021

Improved outcomes with radiation for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900210-4

7 January 2021

A comprehensive review of CT-based dosimetry parameters and biochemical control in patients treated with permanent prostate brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900210-4

7 January 2021

Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900210-4

7 January 2021

Quality of life following prostate cancer treatments

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900210-4

7 January 2021

Patterns and fate of PSA bouncing following 3D-CRT

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900210-4

7 January 2021

Re: Prostate specific antigen bounce after radioactive seed implantation followed by external beam radiation for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900210-4

7 January 2021

Temporary PSA rises and repeat prostate biopsies after brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900210-4

7 January 2021

10.1016/S0360-3016(03)00210-4

Identifiers

DOI

1 reference

13 May 2018

1 reference

13 May 2018